Dr. Zhang on the Selection of Immunotherapy-Based Regimens in Metastatic RCC
Tian Zhang, MD, MHS, discusses the selection of first-line immunotherapy-based treatments for patients with metastatic renal cell carcinoma.
Department Of Internal Medicine Haroldc Simmons Comprehensive Cancer Center Ut Southwestern Medical Center Tian Zhang Internal Medicine Comprehensive Cancer Center
Source: onclive.com